sorafenib tosylate

The medicine is used for the treatment of liver cancer and for the treatment of advanced kidney cancer in patients for whom standard therapy has not been effective or is not indicated.

Form: tablets, film-coated

ATC: L01EX02

Manufacturer: G.L. Pharma GmbH PharOS Mt Ltd Remedica Ltd

The medicine is used to treat liver cancer, advanced kidney cancer (when standard therapy is ineffective or not indicated), and differentiated thyroid cancer.

Form: tablets, film-coated

ATC: L01EB01

Manufacturer: Lek Pharmaceuticals d.d. PharOS Mt Ltd Remedica Ltd

This medicine is used to treat liver cancer (hepatocellular carcinoma) and in the treatment of advanced kidney cancer in patients for whom standard therapy has not been effective or is deemed not indicated.

Form: tablets, film-coated

ATC: L01XE02

Manufacturer: Lek Pharmaceuticals, d.d.

The medicine is used to treat liver cancer, advanced kidney cancer (when standard therapy has not been effective or is not indicated), and thyroid cancer.

Form: tablets, film-coated

ATC: L01EX02

Manufacturer: PharOS Mt Ltd

This medicine is used to treat liver cancer and to treat advanced kidney cancer in patients for whom standard therapy has not been effective or is not indicated.

Form: tablets, film-coated

ATC: L01EX02

Manufacturer: Laboratori Fundacio Dau

The medicine is used to treat liver cancer, advanced kidney cancer (when standard therapy is ineffective or not indicated), and differentiated thyroid cancer.

Form: tablets, film-coated

ATC: L01EX02

Manufacturer: Actavis Group PTC ehf., Merckle GmbH, PLIVA Croatia Ltd., Teva Operations Poland Sp. z o.o., Teva Pharma B.V.

The medicine is used in the treatment of liver cancer, advanced kidney cancer (when standard therapy is ineffective or not indicated), and differentiated thyroid cancer.

Form: tablets, film-coated

ATC: L01EX02

Manufacturer: PharOS MT Ltd. Remedica Ltd